Stock Market & Financial Investment News

News Breaks February 20, 2013 07:37 EDT CELG Celgene feedback on Pomalyst suggest robust uptake, says JPMorgan JPMorgan's physician feedback indicates robust uptake for Pomalyst and more positive than expected. As a result, the firm raised estimates and reiterates its Overweight rating and $115 price target. News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 07:37 EDT CELG Celgene says FDA grants priority review for ABRAXANE sNDA Subscribe for More Information May 20, 2013 09:51 EDT CELG Celgene management to meet with JPMorgan Meetings to be held in Boston on May 22-23 hosted by JPMorgan. May 17, 2013 05:51 EDT CELG Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 11:50 EDT CELG Celgene, Gilead lower after new data published at ASCO Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.